Metabolic syndrome as a risk factor for coronary heart disease and stroke: An 11-year prospective cohort in Taiwan community

Atherosclerosis

Volumn 194, Issue 1, 2007, Pages 214-221

  Chien, Kuo Liong ^a,b   Hsu, Hsiu Ching ^b   Sung, Fung Chang ^a   Su, Ta Chen ^b   Chen, Ming Fong ^b   Lee, Yuan Teh ^b,c  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c Ming Shen Medical Center   (Taiwan)

Author keywords

Community study; Coronary heart disease; Metabolic syndrome; Stroke

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; ASIAN; ATTRIBUTABLE RISK; BODY MASS; CARDIOVASCULAR RISK; COHORT ANALYSIS; COMMUNITY; CONFIDENCE INTERVAL; FEMALE; HAZARD RATIO; HUMAN; HYPERTENSION; INCIDENCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SEX RATIO; STATISTICAL ANALYSIS; STROKE; TAIWAN;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CORONARY DISEASE; FEMALE; HUMANS; INCIDENCE; KAPLAN-MEIERS ESTIMATE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS; SEX DISTRIBUTION; STROKE; TAIWAN;

EID: 34848911661     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2006.07.033     Document Type: Article

References (35)

1. Reaven G.M. Role of insulin resistance in human disease: Banting lecture 1998. Diabetes 37 (1988) 1595-1607
2. DeFronzo R.A., and Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovasular disease. Diab Care 14 (1991) 173-194
3. Boyko E.J., de Courten M.M., Zimmet P.Z., et al. Features of the metabolic syndrome predict higher risk of diabetes and impaired glucose tolerance: a prospective study in Mauritius. Diab Care 23 (2000) 1242-1248
4. Hanson R.L., Imperatore G., Bennett P.H., and Knowler W.C. Components of the "Metabolic Syndrome" and incidence of type 2 diabetes. Diabetes 51 (2002) 3120-3127
5. Zimmet P., Alberti K.G., and Shaw J. Global and societal implications of the diabetes epidemic. Nature 414 (2001) 782-787
6. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001; 285:2486-2497.
7. WHO expert consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 363 (2004) 157-163
8. Reddy K.S. Cardiovascular disease in non-Western countries. N Engl J Med 350 (2004) 2438-2440
9. Chien K.L., Sung F.C., Hsu H.C., et al. Apolipoprotein A1 & B, and stroke events in a community-based cohort in Taiwan: Report of Chin-Shan Community cardiovascular study. Stroke 33 (2002) 39-44
10. Lee Y.T., Lin R.S., Sung F.C., et al. Chin-Shan Community cardiovascular cohort in Taiwan: baseline data and five-year follow-up morbidity and mortality. J Clin Epidemiol 53 (2000) 836-846
11. Wong ND, Sciammarella MG, Polk D et al. The metabolic syndrome, diabetes, and subclinical atherosclerosis assessed by coronary calcium. J Am Coll Cardiol. 41:1547-53.
12. Inoue S, Zimmet P. The Asia-Pacific perspective: redefining obesity and its treatment. Sidney: 2000, Health Communications Australia Pty Limited.
13. The IDF consensus group: The IDF consensus worldwide definition of the metabolic syndrome http://www.idf.org/webdata/docs/MetSyndrome_FINAL.pdf (access at 2006, April, 11).
14. Grundy S.M., Cleeman J.I., Daniels S.R., et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112 (2005) 2735-2752
15. Breslow N.E., and Day N.E. Statistical methods in cancer research, vol. II. The design and analysis of cohort studies (1987), IARC, Lyon
16. Grambsch P.M., and Therneau T.M. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 81 (1994) 515-526
17. D'Agostino Sr. R.B., Grundy S., Sullivan L.M., and Wilson P. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA 286 (2001) 180-187
18. Hanley J.A., and McNeil B.J. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143 (1982) 29-36
19. Hosmer Jr. D.W., and Lemeshow S. Applied logistic regression (1989), John Wiley & Sons, New York
20. Ford E.S., Giles W.H., and Dietz W.H. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 287 (2002) 356-359
21. Hu G., Qiao Q., Tuomilehto J., et al. Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women. Arch Intern Med 164 (2004) 1066-1076
22. Eckel R.H., Grundy S.M., and Zimmet P.Z. The metabolic syndrome. Lancet 365 (2005) 1415-1428
23. Gu D., Reynolds K., Wu X., et al. Prevalence of the metabolic syndrome and overweight among adults in China. Lancet 365 (2005) 1398-1405
24. Thomas G.N., Ho S.Y., Janus E.D., et al. The US National Cholesterol Education Programme Adult Treatment Panel III (NCEP ATP III) prevalence of the metabolic syndrome in a Chinese population. Diab Res Clin Pract 67 (2005) 251-257
25. Resnick H.E. Metabolic syndrome in American Indians. Diab Care 25 (2002) 1246-1247
26. Lindblad U., Langer R.D., Wingard D.L., et al. Metabolic syndrome and ischemic heart disease in elderly men and women. Am J Epi 53 (2001) 481-489
27. Isomaa B.M., Almgren P.M., Tuomi T.M., et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diab Care 24 (2001) 683-689
28. Lakka H.M.M., Laaksonen D.E., Lakka T.A., et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged Men. JAMA 288 (2002) 2709-2716
29. McGovern P.G., Jacobs Jr. D.R., Shahar E., et al. Trends in acute coronary heart disease mortality, morbidity, and medical care from 1985 through 1997: the Minnesota heart survey. Circulation 104 (2001) 19-24
30. Mora S., Lee I., Buring J.E., and Ridker P.M. Association of physical activity and body mass index with novel and traditional cardiovascular biomarkers in women. JAMA 295 (2006) 1412-1419
31. Anuurad E., Shiwaku K., Nogi A., et al. The new BMI criteria for Asians by the regional office for the western Pacific region of WHO are suitable for screening of overweight to prevent metabolic syndrome in elder Japanese workers. J Occup Health 45 (2003) 335-343
32. Pan W.H., Flegal K.M., Chang H.Y., et al. Body mass index and obesity-related metabolic disorders in Taiwanese and US whites and blacks: implications for definitions of overweight and obesity for Asians. Am J Clin Nutr 79 (2004) 31-39
33. Chen H.J., Bai C.H., Yeh W.T., Chiu H.C., and Pan W.H. Influence of metabolic syndrome and general obesity on the risk of ischemic stroke. Stroke 37 (2006) 1060-1064
34. Ota T.M., Takamura T.M., Hirai N.M., and Kobayashi K.M. Preobesity in World Health Organization classification involves the metabolic syndrome in Japanese. Diab Care 25 (2002) 1252-1253
35. Chen T.H., Chiu Y.H., Luh D.L., et al. Community-based multiple screening model: design, implementation, and analysis of 42,387 participants. Cancer 100 (2004) 1734-1743